Most of the therapies listed were identified by the MS Society as relevant, others were added based on Gregory’s findings.

In each section we list the published articles and any clinical trials that include the new drug in the title. In cases where the relevancy of the new drug didn’t come from the MS Society, we also mention it in the page.s

August 14, 2021

Bexarotene

Read more

August 14, 2021

Ocrelizumab

Read more

Subscribe to the email digest

Doctors and Researchers can receive a weekly summary of relevant research articles.